Chie-yu Lin
9Patents
3h-index
11Co-inventors
46Inventor score
Filing activity: Dec 17, 2015 → Dec 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10851357B2 | Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders | Emerging Cross-Sectional Technologies | 16 | Active |
| US10550372B2 | Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems | Emerging Cross-Sectional Technologies | 9 | Active |
| US11597949B2 | Optimized CRISPR-Cas double nickase systems, methods and compositions for sequence manipulation | Chemistry; Metallurgy | 9 | Active |
| US10711285B2 | Optimized CRISPR-Cas double nickase systems, methods and compositions for sequence manipulation | Chemistry; Metallurgy | 3 | Active |
| US11008588B2 | Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation | Chemistry; Metallurgy | 1 | Active |
| US12410435B2 | Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US11597919B2 | Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems | Emerging Cross-Sectional Technologies | 0 | Active |
| US11591581B2 | Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US12258595B2 | Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.